- The International Perspective -
Successful translation of discovery into therapy
Technology transfer from academia to industry is an important part of health innovation. However, the interplay between research institutions, startups, venture capitalists, and pharmaceutical companies is a complex process.
Together with the Heidelberg Startup Partners we organised an intensive afterwork session on October 21st in Heidelberg. Regional and international key opinion leaders discussed best-practice and new ideas in technology transfer.
Christina Takke, Managing Partner at V-Bio Ventures
Joern-Peter Halle, Head of External Innovation & TIP Immuno-Oncology, Merck
Phil Elstob, Commercialisation Director at Cambridge Enterprise
Andreas Jenne, Former CEO at RSP System